Last viewed: SLNO

Prices are updated after-hours

SLNO

Soleno Therapeutics, Inc.

SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

(0.0% 1d) (-9.9% 1m) (882.7% 1y) (0.0% 2d) (0.0% 3d) (-0.9% 7d) (93.13% volume)
Earnings Calendar:
Market Cap: $ 1,308,810,545
http://www.soleno.life
Sec Filling | Patents | 25 employees

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The company focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

metabolic treatment

add to watch list Paper trade email alert is off

Press-releases

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| Email alert Add to watchlist
nasdaq grants therapeutics

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-08 (Crawled : 21:00) - globenewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| Email alert Add to watchlist
nasdaq grants therapeutics

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-03-06 (Crawled : 21:00) - globenewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| -19.06% | O: -7.29% H: 6.93% C: 4.52%
update therapeutics financial results

Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-22 (Crawled : 13:00) - globenewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| -22.77% | O: 0.06% H: 1.54% C: -0.06%
conference health care therapeutics

Soleno Therapeutics to Present at Upcoming February Investor Conferences
Published: 2024-02-01 (Crawled : 13:00) - globenewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| -19.01% | O: 1.83% H: 1.55% C: -0.59%
therapeutics

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-29 (Crawled : 21:00) - globenewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| -21.78% | O: -0.13% H: 0.0% C: -3.71%
nasdaq grants therapeutics

Soleno Therapeutics Strengthens Leadership Team with Key Appointments
Published: 2024-01-24 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -10.09% | O: -3.01% H: 0.69% C: -0.75%
VYGR | News | $7.645 0.99% 0.98% 370K

|

Health Technology

| 0.0% | O: 1.19% H: 0.33% C: -2.61%
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| -21.91% | O: -1.62% H: 1.53% C: -2.07%
SNY | News | $47.69 1.15% 1.13% 1.7M

|

Health Technology

| -7.6% | O: 0.92% H: 0.0% C: 0.0%
PIRS | $12.0 2.67% 2.6% 120K

|

Health Technology

| 6883.27% | O: -3.23% H: 4.2% C: -1.3%
FULC | $7.445 2.69% 2.62% 510K

|

Health Technology

| 7.89% | O: 1.04% H: 2.28% C: -1.33%
key therapeutics

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-05 (Crawled : 13:00) - globenewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| 2.29% | O: -1.47% H: 4.4% C: 2.74%
nasdaq grants therapeutics

Prader-Willi Syndrome Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Leading Companies - Neuren, Aardvark, Jazz, Gedeon Richter, Harmony Biosciences, Soleno Therapeutics
Published: 2023-11-13 (Crawled : 22:00) - prnewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| 70.02% | O: 0.23% H: 3.48% C: 2.08%
companies therapeutics growth market

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-11-10 (Crawled : 21:00) - globenewswire.com
SLNO | $40.32 7.41% 6.89% 420K

|

Health Technology

| Email alert Add to watchlist
nasdaq grants therapeutics

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-24-010250	4	2024-04-04	2024-04-01	Sell	S	888	23422
0001415889-24-010250	4	2024-04-04	2024-04-01	Sell	S	1330	24310
0001415889-24-010247	4	2024-04-04	2024-04-01	Sell	S	2071	62953
0001415889-24-010247	4	2024-04-04	2024-04-01	Sell	S	3104	65024
0001415889-24-010245	4	2024-04-04	2024-04-01	Sell	S	888	50924
0001415889-24-010245	4	2024-04-04	2024-04-01	Sell	S	1330	41812
0001415889-24-010241	4	2024-04-04	2024-04-01	Sell	S	7597	152790
0001415889-24-010241	4	2024-04-04	2024-04-01	Sell	S	11383	160387

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M

|

AGBA | $2.94 135.2% 57.48% 66M

|

EDBL | News | $6.46 71.81% 41.8% 2M

|

MTC | $2.25 44.23% 30.67% 6M

|

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M

|

SHIM | $3.05 35.56% 26.23% 1.1M

|

HKIT | $1.345 31.86% 24.16% 390K

|

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M

|

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K

|

POET | $1.59 27.2% 21.38% 4.2M

|

Last 48 Hours Insiders Buying

MEGI | $11.975 1.87% 0.04% 140K

|

| 00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K

|

| 22:00
CONN | $3.71 1.37% 1.35% 72K

|

| 21:30
TGEN P 6000 | $0.6897 39.71% 2.3K

|

| 18:30
CMTV P 700 | $15.74 17.43% 12K

|

Finance and Insurance

| 18:30
FNB | $13.63 2.17% 0.0% 2.5M

|

| 17:30
RMCF | $3.57 0.28% 2.8K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar